SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-069673
Filing Date
2023-08-22
Accepted
2023-08-22 08:22:58
Documents
3
Period of Report
2023-08-22

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea183968-6k_purplebio.htm 6-K 19451
2 PURPLE BIOTECH REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS ea183968ex99-1_purplebio.htm EX-99.1 129215
3 PURPLE BIOTECH LTD. CONDENSED CONSOLIDATED UNAUDITED INTERIMFINANCIAL STATEMENTS ea183968ex99-2_purplebio.htm EX-99.2 371278
  Complete submission text file 0001213900-23-069673.txt   521172
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 231191015
SIC: 2834 Pharmaceutical Preparations